Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) — Normal, Illinois

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3)?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) conducted?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has 1 clinical trials on record. Their work covers Breast Cancer.

Is Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) accredited by Crixeo Health?

Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Illinois Hematology Oncology Mid Illinois Hema/Onc (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.